Delivery Order SPE2DB22D3501-SPE2DB25FVH30
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,574.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Cosentyx (secukinumab) 300mg dose-2 pens/mL, a medication used to treat certain autoimmune conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,231.56 delivery order contract is for the supply of Cosentyx (secukinumab) 300mg dose syringes, a medication used to treat various autoimmune conditions. The contract is a firm fixed-price, non-set-aside award with a performance period through May 15, 2025. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,594.48 firm fixed-price delivery order is for the supply of Cosentyx (Secukinumab) 300mg dose-2 prefilled syringes. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,774.07 firm fixed-price delivery order is for Cosentyx (secukinumab) 300mg dose pens, a specialty medication used for various autoimmune conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,791.27 firm fixed-price delivery order is for the supply of Cosentyx (secukinumab) 300mg dose-2 pre-filled syringes, with a performance period through May 12, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $15,258.91, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx (secukinumab) 300mg doses, a specialty medication used to treat certain autoimmune conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $66,985.86 firm fixed-price delivery order contract is for the provision of Cosentyx (secukinumab) 300mg/2mL single-dose prefilled pens, with a completion date of October 23, 2024. The contract is not designated as a set-aside and represents a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery...
This federal contract award, with a ceiling value of $28,861.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Cosentyx (secukinumab), a biologic drug used to treat certain autoimmune conditions. The award is not set aside and is a firm fixed-price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,408.39 firm fixed-price delivery order is for the supply of Cosentyx (secukinumab) 300mg dose injections, with a completion date of December 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx (Secukinumab) 300mg medication, a biologic treatment for autoimmune conditions. The contract has a ceiling value of $5,771.66 and a period of performance through January 14, 2025. This appears to be a firm-fixed price delivery order contract, with no set-aside designation...